BACK - IMAC Holdings, Inc. Stock Price, Fair Value and News

3.32USD+0.18 (+5.73%)Delayed as of 17 May 2024, 12:33 pm ET

Market Summary

USD3.32+0.18

Delayedas of 17 May 2024, 12:33 pm

5.73%

BACK Stock Price

View Fullscreen

BACK RSI Chart

BACK Valuation

Market Cap

3.6M

Price/Earnings (Trailing)

-0.59

Price/Sales (Trailing)

6.17

EV/EBITDA

-1.15

Price/Free Cashflow

-2.17

BACK Price/Sales (Trailing)

BACK Profitability

Operating Margin

79.20%

EBT Margin

-531.51%

Return on Equity

494.4%

Return on Assets

-672.64%

Free Cashflow Yield

-46.09%

BACK Fundamentals

BACK Revenue

Revenue (TTM)

606.8K

Rev. Growth (Yr)

-58.64%

Rev. Growth (Qtr)

239.34%

BACK Earnings

Earnings (TTM)

-6.1M

Earnings Growth (Yr)

88.99%

Earnings Growth (Qtr)

72.08%

Breaking Down BACK Revenue

52 Week Range

3.49

(Low)(High)

Last 7 days

-17.4%

Last 30 days

-30.8%

Last 90 days

71.6%

Trailing 12 Months

1862.5%

How does BACK drawdown profile look like?

BACK Financial Health

Current Ratio

0.42

BACK Investor Care

Shares Dilution (1Y)

4.34%

Diluted EPS (TTM)

-5.45

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	14.4M	9.8M	606.8K	0
2022	15.2M	16.8M	17.1M	16.2M
2021	12.6M	13.5M	13.5M	14.4M
2020	15.7M	14.5M	13.6M	12.8M
2019	9.2M	12.3M	14.2M	15.1M
2018	2.3M	3.7M	5.2M	6.7M
2017	0	0	0	786.0K
2016	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Which funds bought or sold BACK recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	TWO SIGMA INVESTMENTS, LP	new	-	34,820	34,820	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	431	17,236	19,945	-%
May 15, 2024	Kestra Advisory Services, LLC	unchanged	-	47,927	172,538	-%
May 15, 2024	MORGAN STANLEY	unchanged	-	142	511	-%
May 13, 2024	HRT FINANCIAL LP	new	-	158,000	158,000	-%
May 13, 2024	UBS Group AG	new	-	704	704	-%
May 13, 2024	CLEAR STREET LLC	sold off	-100	-	-	-%
May 10, 2024	OSAIC HOLDINGS, INC.	added	173	50,592	68,708	-%
May 10, 2024	OSAIC HOLDINGS, INC.	sold off	-100	-12.00	-	-%
May 10, 2024	WELLS FARGO & COMPANY/MN	added	14.29	9.00	24.00	-%

Are Funds Buying or Selling BACK?

Are funds buying BACK calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own BACK

No. of Funds

Recent SEC filings of IMAC Holdings, Inc.

View All Filings

Date Filed	Form Type	Document
May 16, 2024	8-K	Current Report
May 15, 2024	10-Q	Quarterly Report
May 07, 2024	RW	RW
May 07, 2024	8-K	Current Report
May 02, 2024	10-K/A	Annual Report
May 01, 2024	8-K	Current Report
Apr 25, 2024	D	D
Apr 16, 2024	8-K	Current Report
Apr 16, 2024	10-K	Annual Report
Apr 01, 2024	NT 10-K	NT 10-K

Peers (Alternatives to IMAC Holdings, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	479.9B	379.5B	11.20%	7.55%	31.24	1.26	12.96%	-25.81%
CI	96.4B	206.0B	-2.18%	28.90%	25.01	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	2.85%	17.20%	15.46	1.27	9.59%	-4.59%
CVS	72.2B	360.9B	-16.66%	-17.14%	9.86	0.2	9.07%	78.49%
CNC	41.2B	155.5B	6.71%	14.75%	15.05	0.26	6.34%	84.42%
UHS	12.0B	14.7B	10.86%	33.14%	14.73	0.82	7.99%	19.23%
DVA	12.0B	12.3B	5.19%	38.43%	14.68	0.97	5.77%	58.74%
MID-CAP
CHE	8.6B	2.3B	-6.84%	5.15%	30.33	3.75	5.96%	18.29%
ACHC	6.2B	3.0B	-6.14%	-7.19%	-547.09	2.07	10.92%	-104.06%
AMEH	2.3B	1.5B	8.58%	22.04%	36.93	1.59	19.34%	40.15%
AMN	2.2B	3.5B	3.96%	-38.10%	15.61	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	13.47%	25.04%	27.49	1.66	11.45%	30.74%
BKD	1.4B	3.0B	11.90%	88.00%	-7.82	0.45	4.98%	4.88%
BEAT	55.6M	-	17.22%	-3.21%	-3.68	-	-	-1.05%
AMS	21.1M	21.6M	17.97%	25.63%	38.19	0.98	9.04%	-50.63%

IMAC Holdings, Inc. News

Latest updates

IMAC Holdings, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Revenue	-	-	-	1,565,820	461,431	1,277,397	2,093,362	3,471,380	3,786,228	5,033,088	3,894,987	4,368,564	3,487,496	3,465,515	3,064,253	3,463,221	3,477,841	2,572,580	3,321,556	4,243,539	4,355,904	3,756,755
Cost Of Revenue	-	-	-	39,909	50,084	-	-	-	-	99,484	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	139,358	152,363	-	-	-	-	64,729	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	106.2%	408,630	-6,602,797	4,463,431	2,724,925	-	5,789,548	-12,169,341	10,132,387	6,834,245	7,039,807	7,216,133	6,274,382	5,878,271	5,117,397	4,988,355	4,785,594	4,282,041	5,315,501	5,335,101	5,993,387	5,868,716
S&GA Expenses	100.0%	-	-2,062,950	1,129,384	886,632	-	1,504,878	-3,073,570	1,866,037	1,857,915	1,815,247	1,939,231	1,603,056	1,661,193	1,219,338	1,150,438	961,521	1,208,457	1,236,138	1,345,931	1,311,315	1,429,822
EBITDA Margin	49.8%	-5.15	-10.26	-14.32	-2.28	-1.22	-0.83	-0.69	-0.73	-0.53	-0.62	-0.58	-0.40	-0.29	-0.27	-	-	-	-	-	-	-
Interest Expenses	43.0%	40,473	28,311	71,830	22,358	-	2,467	-8,688	2,976	4,733	4,131	93,281	108,315	126,228	176,279	210,526	141,416	134,921	76,204	68,198	74,456	85,210
Earnings Before Taxes	-130.2%	-448,899	1,484,672	-2,857,671	-1,403,307	-	-3,698,653	-491,136	-6,333,625	-1,844,099	-3,162,125	-2,881,452	-2,892,631	-2,538,741	-2,229,423	-24,778	-1,472,399	-1,975,112	-2,070,149	-1,012,765	-1,711,913	-2,196,501
EBT Margin	50.2%	-5.32	-10.67	-13.93	-2.29	-1.26	-0.86	-0.73	-0.83	-0.64	-0.75	-0.73	-0.57	-0.47	-0.45	-	-	-	-	-	-	-
Net Income	72.1%	-407,219	-1,458,555	-2,857,671	-1,403,307	-	-3,698,653	-36,456,347	-6,333,625	-1,844,099	-3,162,125	-1,512,267	-2,892,631	-2,538,741	-2,229,423	-24,778	-1,472,399	-1,975,112	-2,070,149	-1,084,835	-1,548,962	-2,196,501
Net Income Margin	34.9%	-10.10	-15.52	-73.20	-9.21	-4.94	-3.36	-2.95	-0.75	-0.56	-0.66	-0.64	-0.57	-0.47	-0.45	-	-	-	-	-	-	-
Free Cashflow	-756.9%	-357,652	54,449	-1,572,294	-298,148	-1,463,020	-1,463,020	-2,119,157	-1,680,040	-3,308,397	-2,810,690	-2,172,362	-1,541,410	-2,755,895	-1,815,671	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-20.4%	911	1,144	4,264	4,645	5,843	11,082	2,599	22,068	24,200	27,229	29,881	32,532	33,628	19,746	19,374	21,861	21,104	20,418	21,017	22,409	17,990
Current Assets	-20.4%	911	1,144	2,072	1,276	1,802	10,830	647	5,372	6,678	9,068	639	16,263	18,299	4,757	3,792	4,893	3,541	2,578	2,163	4,022	4,132
Cash Equivalents	-92.1%	18.00	222	225	247	390	763	393	1,614	4,275	7,119	314	13,622	15,608	2,624	1,664	2,803	1,282	374	741	2,231	3,066
Net PPE	-	-	-	277	566	683	5.00	686	2,050	2,285	2,323	699	1,869	1,831	1,777	1,862	3,294	3,531	3,692	4,005	3,589	3,221
Goodwill	-	-	-	-	-	-	-	4,500	4,662	4,662	4,662	2,041	2,041	2,041	2,041	2,041	2,041	2,041	2,041	2,042	2,042	2,042
Liabilities	13.4%	2,150	1,897	3,236	5,004	4,846	6,430	6,400	7,973	9,228	9,276	3,584	10,154	10,795	11,933	12,882	13,937	13,821	12,481	13,255	13,121	10,904
Current Liabilities	13.4%	2,150	1,897	2,459	3,924	3,532	6,430	3,456	4,563	5,238	4,934	3,296	5,438	6,601	5,950	6,041	8,771	9,285	6,066	5,931	6,150	6,502
LT Debt, Current	-	-	-	9,931	5,187	-	-	1,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-64.6%	-1,239	-752	1,028	-	997	4,651	11,555	14,095	14,972	17,953	19,525	22,378	22,833	7,813	6,492	7,924	7,283	7,937	7,762	9,287	7,086
Retained Earnings	-0.7%	-56,345	-55,938	-54,534	-51,621	-50,218	-46,519	-62,807	-33,213	-31,369	-28,206	-49,825	-22,432	-19,894	-17,664	-17,639	-16,167	-14,192	-12,122	-8,593	-7,044	-5,144
Additional Paid-In Capital	-0.1%	55,105	55,185	51,262	51,262	51,182	51,170	55,392	47,281	46,315	46,159	44,368	44,786	42,703	25,465	24,120	24,080	21,465	20,051	18,863	18,677	14,280
Shares Outstanding	0%	1,148	1,148	1,109	1,109	1,101	1,098	914	893	879	874	844	838	448	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-4,572	-3,400	-2,858	-2,618	-2,403	-2,361	-2,416	-2,080	-2,515	-2,352	-2,057
Float	-	-	-	-	3,300	-	-	-	6,000	-	-	-	17,000	-	17,000	-	-	-	-	-	23,500	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-196.4%	-202	210	-1,416	-252	-1,417	-2,073	-1,643	-3,270	-2,592	-1,849	-1,410	-2,580	-1,749	-1,973	-1,035	-1,827	-1,157	-1,273	-1,116	-784	-894
Share Based Compensation	100.0%	-	-7.54	-524	1,012	86.00	91.00	84.00	703	41.00	148	188	123	111	81.00	108	122	81.00	104	113	172	4.00
Cashflow From Investing	-100.0%	-	95.00	-1,577	80.00	1,050	-44.04	-2.57	-38.14	-216	-1,301	-119	-353	-683	-73.36	-42.11	-247	-207	-364	-298	-347	-42.43
Cashflow From Financing	99.3%	-1.72	-264	3,448	30.00	-5.53	48.00	2,390	647	-35.10	-923	-897	948	15,417	3,006	-61.05	3,596	2,273	1,271	-75.43	298	3,808

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

BACK Income Statement

2024-03-31

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Income Statement [Abstract]

Patient revenues, net

Total revenue

Operating expenses:

Salaries and benefits

150,202

637,817

Advertising and marketing

7,732

^[1]

General and administrative

258,428

603,440

Depreciation and amortization

47,177

Loss on disposal or impairment of assets

(148)

Total operating expenses

408,630

1,296,018

Operating loss

(408,630)

(1,296,018)

Other expenses:

Interest income

204

Interest expense

(40,473)

(846)

Total other expenses

(40,269)

(844)

Net loss before income taxes

(448,899)

(1,296,862)

Income taxes

Net loss from continuing operations

(448,899)

(1,296,862)

Income (Loss) from operations of discontinued component

41,680

(960,632)

Income (Loss) on disposal of discontinued operations

(1,441,159)

Income (Loss) on discontinued operations

41,680

(2,401,791)

Net loss

$ (407,219)

$ (3,698,653)

Net loss per share from continuing operations - basic

$ (0.39)

$ (1.18)

Net loss per share from continuing operations - diluted

(0.39)

(1.18)

Income (Loss) per share from discontinued operations - basic

0.040

(2.18)

Income (Loss) per share from discontinued operations - diluted

0.040

(2.18)

Net loss per share - basic

(0.35)

(3.36)

Net loss per share - diluted

$ (0.35)

$ (3.36)

Weighted average common shares outstanding - basic

1,148,321

1,100,439

Weighted average common shares outstanding - diluted

1,148,321

1,100,439

[1]	As discussed in Note 1, the Company decided to discontinue business activities related to its underperforming clinic locations and BackSpace retail stores. See Note 2 for the resulting impact on this previous disclosed amount.

BACK Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($)

Mar. 31, 2024

Dec. 31, 2023

Current assets:

Cash

$ 17,535

$ 221,511

Accounts receivable, net

^[1]

Other assets

66,177

94,711

Note receivable, net

731,067

Assets of discontinued operations

96,068

96,830

Total current assets

910,847

1,144,119

Total assets

910,847

1,144,119

Current liabilities:

Accounts payable and accrued expenses

836,567

584,055

Liabilities of discontinued operations

1,313,511

1,312,711

Total current liabilities

2,150,078

1,896,766

Total liabilities

2,150,078

1,896,766

Commitment and Contingencies – Note 12

Stockholders’ deficit:

Preferred stock - $0.001 par value, 5,000,000 authorized, 2,645 Series B-1 and 1,905 Series B-2 issued and outstanding at March 31, 2024 and December 31, 2023.

Common stock - $0.001 par value, 60,000,000 authorized; 1,148,321 issued and outstanding at March 31, 2024 and December 31, 2023.

1,149

Additional paid-in capital

55,105,159

55,184,524

Accumulated deficit

(56,345,544)

(55,938,325)

Total stockholders’ deficit

(1,239,231)

(752,647)

Total liabilities and stockholders’ deficit

$ 910,847

$ 1,144,119

[1]	As discussed in Note 1, the Company decided to discontinue business activities related to its underperforming clinic locations and BackSpace retail stores. See Note 2 for the resulting impact on this previous disclosed amount.

About IMAC Holdings, Inc.

IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

CEO	Mr. Jeffrey S. Ervin M.B.A.
WEBSITE	imacholdings.com
INDUSTRY	Healthcare Plans
EMPLOYEES	85

IMAC Holdings, Inc. Frequently Asked Questions

What is the ticker symbol for IMAC Holdings, Inc.? What does BACK stand for in stocks?

BACK is the stock ticker symbol of IMAC Holdings, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of IMAC Holdings, Inc. (BACK)?

As of Thu May 16 2024, market cap of IMAC Holdings, Inc. is 3.61 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BACK stock?

You can check BACK's fair value in chart for subscribers.

What is the fair value of BACK stock?

You can check BACK's fair value in chart for subscribers. The fair value of IMAC Holdings, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of IMAC Holdings, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BACK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is IMAC Holdings, Inc. a good stock to buy?

The fair value guage provides a quick view whether BACK is over valued or under valued. Whether IMAC Holdings, Inc. is cheap or expensive depends on the assumptions which impact IMAC Holdings, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BACK.

What is IMAC Holdings, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, BACK's PE ratio (Price to Earnings) is -0.59 and Price to Sales (PS) ratio is 6.17. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BACK PE ratio will change depending on the future growth rate expectations of investors.